TRAF3 and lung adenocarcinoma: Our findings suggest that TRAF3 inhibition can facilitate the proliferation and migration of lung adenocarcinoma cells, and reduce the sensitivity of LUAD cells to paclitaxel, partly by mediating the caspase-1-dependent pyroptosis.